Impact Biomedical (IBO) Net Cash Flow (2022 - 2026)
Impact Biomedical (IBO) posted Net Cash Flow of $17000.0 for Q1 2026, down 83.0% on a QoQ basis from $100000.0 in Q4 2025, and up 102.5% year-over-year from $8395.2 in Q1 2025.
Impact Biomedical (IBO) Net Cash Flow (2022 - 2026) Analysis & Trends
Impact Biomedical's Net Cash Flow history runs 5 years deep, the most recent figure standing at $17000.0 for Q1 2026.
- Quarterly Net Cash Flow rose 102.5% year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 190.42% YoY) and the FY2025 annual result came in at -$2.0 million, down 199.9% from the prior year.
- Net Cash Flow was $17000.0 for Q1 2026 at Impact Biomedical, down from $100000.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $2.7 million in Q3 2024 and bottomed at -$694000.0 in Q2 2025.
- A 5-year average of -$200.0 and a median of -$1000.0 in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow soared 1246.46% — and 2025, when it plunged 69300.0%.
- Impact Biomedical's Net Cash Flow stood at -$99000.0 in 2022, then sank by 102.02% to -$200000.0 in 2023, then sank by 234.5% to -$669000.0 in 2024, then soared by 114.95% to $100000.0 in 2025, then plunged by 83.0% to $17000.0 in 2026.
- Business Quant data shows IBO's Net Cash Flow at $17000.0 in Q1 2026, $100000.0 in Q4 2025, and -$612000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | -612,000.00 |
| Sep 30, 2025 | -612,000.00 |
| Jun 30, 2025 | -694,000.00 |
| Jun 30, 2025 | -694,000.00 |
| Mar 31, 2025 | -681,000.00 |
| Mar 31, 2025 | -681,000.00 |
| Dec 31, 2024 | -669,000.00 |
| Dec 31, 2024 | -669,000.00 |
| Sep 30, 2024 | 2.67 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Dec 31, 2023 | -200,000.00 |